Applied Radiology

By News Release Published Date: September 1, 2026 GE HealthCare has announced that its photon-counting computed tomography (PCCT) system, Photonova Spectra, has obtained the CE Mark, following FDA 510(k) clearance and approval in Japan. This enables greater adoption of the technology across Europe and other regions observing CE Mark standards.

By News Release Published Date: September 1, 2026 Recent research has demonstrated that lumbar CT scans using Hounsfield unit (HU) measurements offer superior diagnostic accuracy over MRI-derived vertebral bone quality (VBQ) scores in detecting osteopenia and osteoporosis. This systematic review and meta-analysis, published in European Radiology, highlights the potential for lumbar CT to be integrated into routine bone density screening practices.

By News Release Published Date: September 1, 2026 A recent study conducted by the Harvey L. Neiman Health Policy Institute has uncovered significant insights into imaging utilization patterns among Medicare beneficiaries. The research indicates that clinicians who interpret the imaging they order are associated with heightened imaging use compared to those who refer these tasks to radiologists.

By News Release Published Date: August 31, 2026 Recent research suggests that superresolution ultrasound (US) technology may redefine the detection of diabetic peripheral neuropathy (DPN) by uncovering intricate microvascular changes in the tibial nerve. The study, published in Radiology and led by Dr Fang Liu of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, identifies increased nerve blood flow and vascularity in patients with DPN and ulcers.

Published Date: August 31, 2026 An investigational PET radiotracer demonstrated high sensitivity and specificity for diagnosing cardiac amyloidosis in the Phase III REVEAL study, according to results presented at the European Society of Cardiology (ESC) Congress 2026 and simultaneously published in JAMA. The multicenter, open-label, single-arm study evaluated iodine 124 evuzamitide (I-124 evuzamitide) in 170 adults with suspected cardiac amyloidosis at 18 US centers.

By News Release Published Date: August 27, 2026 Intermountain Medical Center, based in Murray, Utah, has become a pioneer in the state as the first hospital to implement the GE HealthCare SIGNA Sprint Elite MRI system. This advanced imaging innovation, utilized by only one other facility in the United States, is now operational and aims to significantly improve diagnostic capabilities for patients with cardiac and oncological conditions.

By News Release Published Date: August 27, 2026 The University of Texas Medical Branch (UTMB) has commenced recruitment for a U.S. Phase 2 clinical trial, examining a promising imaging compound designed to enhance the visualization of brain tumors during surgical procedures. This investigational agent, FG001, developed by FluoGuide A/S in Denmark, aims to assist neurosurgeons in delineating the borders between tumors and healthy brain tissue in patients with newly diagnosed high-grade gliomas.

By News Release Published Date: August 27, 2026 Philips, a leader in health technology, has partnered with Imricor Medical Systems to introduce an advanced Interventional MR (iMR) lab solution, integrating Philips' high-performance 1.5T MRI platform with Imricor's MR-compatible systems for cardiac interventions. This collaboration marks a significant step in expanding the use of MRI technology from diagnostic to therapeutic cardiovascular applications.

By News Release Published Date: August 26, 2026 Recent findings from two large registry studies indicate that high-intensity focused ultrasound (HIFU) could be a viable first-line treatment for localized prostate cancer. The Sonablate device was assessed over a decade, focusing on its effectiveness in delivering focal therapy, an organ-preserving treatment that targets only cancerous prostate tissue.

By News Release Published Date: August 26, 2026 The Focused Ultrasound Foundation has partnered with Bracco Imaging to expand access to the research version of Bracco's SonoVue microbubble formulation, known as BR1. This partnership is designed to accelerate preclinical research using focused ultrasound technology worldwide.